Court upholds patenting of genes in Myriad case
by admin on Friday, July 29th, 2011 | No Comments
CHICAGO (Reuters) – A federal appeals court affirmed the right of Heap Genetics to patent two genes linked to breast cancer, overturning a lower court ruling that threatened a key element of the biotech business.
View full post on Reuters: Business News
